News Releases

Unaudited cash, revenue and loss for the year expected to be ahead of expectations LONDON, U.K AND DALLAS, TX, U.S.  – Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment

Accomplished technology executive and innovator Dr. Niko Pagoulatos joins Spectral MD LONDON, U.K AND DALLAS, TX, U.S.  – Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms and optical technology for rapid and accurate treatment decisions in wound

LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI and optical technology for faster and more accurate treatment decisions in wound care, announces that a block listing application (“Block Listing”) has been made to the London

Spectral MD expected to exceed full year market expectations for revenue, margins, and EBITDA Burn and Diabetic Foot Ulcer (“DFU”) clinical studies remain on track LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms

LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that Erich Spangenberg, Non-Executive Director, has elected to

LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces the exercise of options by certain employees of the Company (the

Study assesses Emergency Medicine Physicians’ ability to measure burn depth LONDON, U.K. AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care,

LONDON, U.K AND DALLAS, TX, U.S . Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI and optical technology for faster and more accurate treatment decisions in wound care, announces that at the AGM held earlier today, all resolutions were duly passed.

Extensive solution validation; accelerating commercialization readiness LONDON, U.K. AND DALLAS, TX, U.S –  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound

LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI and optical technology for faster and more accurate treatment decisions in wound care, announces that it will release its interim results for the six months ended 30 June 2022